Otto, Michael
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2025 Rank: 1,187
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 18 out of 217,955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1,187 | 1,281 |
| Total Cites | 2,697 | 2,792 |
| H-index | 26 | 27 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 429 | 434 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 443 | 449 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 1,864 | 1,908 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,809 | 1,832 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.52 |
| Self-Citation Percentage |
3.40%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 14 out of 204,759 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1,016 | 976 |
| Total Cites | 2,522 | 2,759 |
| H-index | 26 | 27 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 440 | 461 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 465 | 490 |
| Number of Single+First+Last Authored Papers | 164 | 164 |
| Total Cites to Single+First+Last Authored Papers | 1,688 | 1,834 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 1,683 | 1,720 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.60 |
| Self-Citation Percentage |
8.59%
|
|
Otto, Michael
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2023 Rank: 860
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 16 out of 190,396 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 860 | 888 |
| Total Cites | 2,520 | 2,699 |
| H-index | 26 | 27 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 515 | 531 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 537 | 556 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 1,680 | 1,767 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 1,668 | 1,697 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.59 |
| Self-Citation Percentage |
6.63%
|
|
Otto, Michael
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2022 Rank: 784
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 14 out of 175,943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 784 | 812 |
| Total Cites | 2,535 | 2,727 |
| H-index | 26 | 27 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 566 | 574 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 589 | 597 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 1,633 | 1,723 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 1,611 | 1,648 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.65 |
| Self-Citation Percentage |
7.04%
|
|
Otto, Michael
National Institute of Allergy and Infectious Diseases (NIAID),
United States
2021 Rank: 827
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 14 out of 165,244 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 827 | 888 |
| Total Cites | 3,635 | 3,937 |
| H-index | 31 | 31 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 38 | 38 |
| Total Cites to Single Authored Papers | 776 | 798 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 818 | 845 |
| Number of Single+First+Last Authored Papers | 146 | 146 |
| Total Cites to Single+First+Last Authored Papers | 2,330 | 2,495 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 2,338 | 2,407 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.64 |
| Self-Citation Percentage |
7.67%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 11 out of 134,369 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 869 | 863 |
| Total Cites | 2,776 | 3,012 |
| H-index | 27 | 28 |
| Hm-index | 17 | 17 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 584 | 605 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 619 | 644 |
| Number of Single+First+Last Authored Papers | 140 | 140 |
| Total Cites to Single+First+Last Authored Papers | 1,766 | 1,892 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 1,765 | 1,814 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.66 |
| Self-Citation Percentage |
7.84%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.